Thrombolytic therapy in patients with mild stroke
10.3760/cma.j.issn.1673-4165.2015.11.009
- VernacularTitle:轻症卒中的溶栓治疗
- Author:
Yanan LIN
;
Yu WANG
;
Xiaopei SUN
- Publication Type:Journal Article
- Keywords:
Stroke;
Brain Ischemia;
Thrombolytic Therapy;
Tissue Plasminogen Activator
- From:
International Journal of Cerebrovascular Diseases
2015;23(11):849-853
- CountryChina
- Language:Chinese
-
Abstract:
Mild stroke refers to ischemic stroke with mild neurological defects.In recent years,its incidence rate has increased gradually.However,there is no standardized definition for mild stroke,and there is a great controversy about whether to conduct thrombolytic therapy for mild stroke.The conventional wisdom holds that the patients with mild stroke should not be treated with intravenous thrombolysis;however,many studies have indicated that the short-term and medium-term outcomes are poor in patients with mild stroke without receiving thrombolytic therapy,and many patients with mild stroke may benefit from thrombolytic therapy.This article summarizes about the definition of mild stroke and the clinical studies of thrombolytic therapy in recent years,hoping to provide reference for clinicians in order to make better clinical decisions.
